Has Deborah Anghesom-Negusse, MD received payments from drug or device companies?

Yes. Drug and device makers reported $917 in general payments to Deborah Anghesom-Negusse, MD across 42 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Deborah Anghesom-Negusse, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Deborah Anghesom-Negusse, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Deborah Anghesom-Negusse, MD

Gastroenterology · Rancho Cucamonga, CANPI 1780862169

Payments from drug & device makers

$917in general payments, 2019–2025

Across 42 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$328
Boston Scientific$100
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$86
Takeda Pharmaceuticals U.S.A., Inc.$72
Conmed Corporation$64
Novo Nordisk$59
plus $208 from 6 others

What the payments were for

Food & beverage$90398%
Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	16	$328
Boston Scientific	2	$100
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$86
Takeda Pharmaceuticals U.S.A., Inc.	6	$72
Conmed Corporation	1	$64
Novo Nordisk	2	$59
Phathom Pharmaceuticals, Inc.	2	$55
Redhill Biopharma Inc.	3	$45
Braintree Laboratories, Inc.	2	$36
Ardelyx, Inc.	1	$29
Ironwood Pharmaceuticals, Inc	1	$24
Intercept Pharmaceuticals, Inc.	1	$19

How this compares

$917 in reported general payments places this provider in the 35th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024

$123,289

Medicare patients

364

Services billed

867

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	61	$805
Hydrocortisone	36	$641
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	24	$372
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl	18	$365
Procto-Med HcHydrocortisone	20	$238
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	11	$227
Famotidine	15	$211
Pantoprazole Sodium	11	$189

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Rancho Cucamonga

Peter WinkleCypress$116.7M
Manuchehr DaraniSanta Ana$17.7M
Jatinder PruthiLancaster$4.4M
Long DangWestminster$4.3M
Muhammad SheikhFresno$4.3M
Gregory WienerChula Vista$3.5M
Gil MelmedLos Angeles$3M
Christopher BowlusSacramento$3M
Bennett RothLos Angeles$2.8M
Brigid BolandSan Diego$2.4M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →